🇺🇸 FDA
Patent

US 7655694

Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury

granted A61KA61K31/352A61K31/7048

Quick answer

US patent 7655694 (Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/352, A61K31/7048, A61K36/48, A61K41/00